Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States.

Ashley C PariserTannaz SedghiPamela R SoulosBrigid KilleleaCary P GrossSarah S Mougalian

Published in: Breast cancer research and treatment (2019)

Women who received NET had similar rates of BCS compared to women who received NAC. Those who received NET for longer treatment durations had increased odds of BCS and downstaging compared to women who did not receive neoadjuvant therapy.

Keyphrases

polycystic ovary syndrome
rectal cancer
pregnancy outcomes
lymph node
locally advanced
cervical cancer screening
breast cancer risk
transcription factor
insulin resistance
radiation therapy
mesenchymal stem cells
metabolic syndrome